ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
AKTIENPREIS
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership20,332 shares
Latest Disclosed Value $ 1,605,008
Alliancebernstein L.p. reports 0.09% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 20,332 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $1,605,008 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,314 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 0.09% during the quarter. The current value of the position is $1,108,094 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 20,332 18 0.09 1,605 0.12 0.0005
2026-02-17 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 20,314 4 0.02 1,604 -13.82 0.0005
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 20,310 300 1.50 1,860 42.53 0.0006
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 20,010 0 0.00 1,306 -2.54 0.0004
2025-05-15 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 20,010 0 0.00 1,340 21.07 0.0005
2025-02-12 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 20,010 0 0.00 1,106 -7.29 0.0004
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 20,010 0 0.00 1,194 -6.36 0.0004
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 20,010 4,100 25.77 1,274 15.92 0.0004
2024-05-14 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 15,910 1,630 11.41 1,100 39.64 0.0004
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,280 0 0.00 787 -5.07 0.0003
2023-11-14 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,280 0 0.00 829 7.94 0.0004
2023-08-15 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,280 1,330 10.27 769 49.42 0.0003
2023-05-15 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 12,950 -1,803 -12.22 514 -13.32 0.0002
2023-02-15 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,753 33 0.22 594 25.37 0.0003
2022-11-15 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,720 -135 -0.91 473 7.26 0.0002
2022-08-15 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,855 72 0.49 441 6.01 0.0002
2022-05-13 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 14,783 290 2.00 416 -37.72 0.0002
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,493 -3,117 -17.70 668 15.57 0.0002
2021-11-10 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 17,610 -450 -2.49 578 -8.69 0.0002
2021-07-30 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,060 -3,609 -16.66 633 -19.16 0.0003
2021-05-06 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 21,669 2,250 11.59 783 38.83 0.0003
2021-02-08 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 19,419 1,207 6.63 564 9.73 0.0003
2020-11-12 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 18,212 -714 -3.77 514 -16.01 0.0003
2020-08-13 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,926 4,826 34.23 612 6.62 0.0004
2020-05-14 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 14,100 -400 -2.76 574 -35.79 0.0004
2020-02-18 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,500 50 0.35 894 -15.10 0.0005
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,450 -1,700 -10.53 1,053 -20.71 0.0007
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 16,150 5,900 57.56 1,328 83.68 0.0008
2019-05-14 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,250 0 0.00 723 56.83 0.0005
2019-02-13 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 10,250 0 0.00 461 -20.52 0.0003
2018-11-08 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 10,250 0 0.00 580 -15.33 0.0004
2018-08-13 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 10,250 900 9.63 685 25.92 0.0005
2018-05-14 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,350 -10,938 -53.91 544 -58.41 0.0004
2018-02-13 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 20,288 10,838 114.69 1,308 163.71 0.0009
2017-11-13 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,450 -1,100 -10.43 496 0.40 0.0004
2017-08-10 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 10,550 2,600 32.70 494 25.38 0.0004
2017-05-11 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 7,950 -48,300 -85.87 394 -88.45 0.0003
2017-02-13 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 56,250 4,800 9.33 3,410 -0.12 0.0028
2016-11-10 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 51,450 23,770 85.87 3,414 120.97 0.0029
2016-08-11 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 27,680 16,330 143.88 1,545 304.45 0.0013
2016-05-13 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,350 0 0.00 382 -25.39 0.0003
2016-02-16 2015-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 11,350 0 0.00 512 14.29 0.0004
2016-02-12 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 11,350 448
2015-11-13 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 11,350 0 0.00 448 -36.36 0.0004
2015-08-14 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 11,350 7,400 187.34 704 185.02 0.0006
2015-05-13 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 3,950 -1,400 -26.17 247 -18.21 0.0002
2015-02-13 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 5,350 2,550 91.07 302 282.28 0.0003
2014-11-13 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,800 0 0.00 79 -17.71 0.0001
2014-08-13 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,800 2,601 1,307.04 96 1,500.00 0.0001
2014-05-13 2014-03-31 13F ANI PHARMACEUTICALS COM 00182C103 199 0 0.00 6 50.00 0.0000
2014-02-13 2013-12-31 13F ANI PHARMACEUTICALS COM 00182C103 199 0 0.00 4 100.00 0.0000
2013-11-14 2013-09-30 13F ANI PHARMACEUTICALS COM 00182C103 199 199 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.